[
  {
    "patent_id": "US847230A1",
    "title": "melamine pain management novel formulation and delivery mechanism",
    "assignee": "Generic Pharma Co.",
    "inventors": [
      "John Doe",
      "Emily Zhang"
    ],
    "filing_year": 2017,
    "publication_year": 2021,
    "expiry_year": 2040,
    "therapeutic_area": "Pain management",
    "abstract": "This invention relates to an improved pharmaceutical formulation of melamine, designed for enhanced pain management. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Active",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US620544A1",
    "title": "melamine liver safety formulations novel formulation and delivery mechanism",
    "assignee": "Dr. Reddy’s Laboratories",
    "inventors": [
      "John Doe",
      "Carlos Gomez"
    ],
    "filing_year": 2021,
    "publication_year": 2017,
    "expiry_year": 2034,
    "therapeutic_area": "Liver safety formulations",
    "abstract": "This invention relates to an improved pharmaceutical formulation of melamine, designed for enhanced liver safety formulations. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Expired",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US803071A1",
    "title": "melamine pediatric dosing novel formulation and delivery mechanism",
    "assignee": "Generic Pharma Co.",
    "inventors": [
      "Michael Lee",
      "Emily Zhang"
    ],
    "filing_year": 2015,
    "publication_year": 2024,
    "expiry_year": 2037,
    "therapeutic_area": "Pediatric dosing",
    "abstract": "This invention relates to an improved pharmaceutical formulation of melamine, designed for enhanced pediatric dosing. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Pending",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US956603A1",
    "title": "melamine inflammation novel formulation and delivery mechanism",
    "assignee": "Sun Pharma",
    "inventors": [
      "John Doe",
      "Carlos Gomez"
    ],
    "filing_year": 2016,
    "publication_year": 2022,
    "expiry_year": 2040,
    "therapeutic_area": "Inflammation",
    "abstract": "This invention relates to an improved pharmaceutical formulation of melamine, designed for enhanced inflammation. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Expired",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US192757A1",
    "title": "melamine liver safety formulations novel formulation and delivery mechanism",
    "assignee": "Dr. Reddy’s Laboratories",
    "inventors": [
      "Priya Nair",
      "Rajesh Kumar"
    ],
    "filing_year": 2018,
    "publication_year": 2017,
    "expiry_year": 2034,
    "therapeutic_area": "Liver safety formulations",
    "abstract": "This invention relates to an improved pharmaceutical formulation of melamine, designed for enhanced liver safety formulations. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Active",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US407637A1",
    "title": "melamine fever reduction novel formulation and delivery mechanism",
    "assignee": "Sun Pharma",
    "inventors": [
      "John Doe",
      "Anna Petrova"
    ],
    "filing_year": 2018,
    "publication_year": 2021,
    "expiry_year": 2033,
    "therapeutic_area": "Fever reduction",
    "abstract": "This invention relates to an improved pharmaceutical formulation of melamine, designed for enhanced fever reduction. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Active",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  }
]